The Brighterside of News on MSN
New drug combination boosts life expectancy from grade 3 brain tumors by 45% or more
A new international study has delivered a rare dose of good news in the fight against aggressive brain tumors. Researchers ...
This type of brain tumor can range from slow-growing to highly aggressive forms. Learn how astrocytomas are diagnosed and treated and what factors influence a person’s outlook and recovery.
Looking for reliable medications to treat 'Astrocytoma'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications. For informed ...
A pilocytic astrocytoma (PA) or juvenile pilocytic astrocytoma (JPA) is a tumor in the primary central nervous system (CNS). It refers to abnormal growth of the brain and spinal cord cells that make ...
Astrocytomas develop from a type of glial cell called an astrocyte. There are low grade and high grade astrocytomas (gliomas). Around 175 children are diagnosed with an astrocytoma each year in the UK ...
Astrocytoma is the most common type of glioma tumor that can develop in the brain and spinal cord. It’s more common in men than women and most often shows up after age 45. There are several types of ...
Q: Who should I consult when I have symptoms like memory loss, headaches and seizures? A: These symptoms can be seen in many disorders that affect the brain, hence you should first consult your ...
The first FDA-approved systemic therapy may be beneficial to patients with low-grade astrocytoma or oligodendroglioma with IDH1 or 2 mutations. The recent Food and Drug Administration (FDA) approval ...
The FDA has approved Voranigo to treat certain patients with grade 2 astrocytoma or oligodendroglioma with select mutations, following surgery. The Food and Drug Administration (FDA) has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results